Skip to main content

Table 1 Description of baseline characteristics of HIV-infected infants treated by cART for at least 3 months (ANRS-PEDIACAM Study, 2008-2013, Cameroon)

From: Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?

  N = 167
Variables (n, % of missing data) N % (n) or median (IQR)
Male sex 167 45.5 (76)
Infant group at inclusion 167  
 Followed since birth   37.7 (63)
 Not followed since birth but diagnosed before age 7 months   62.3 (130)
Recruitment sites 167  
 CME/FCB   47.3 (79)
 HLD   23.4 (39)
 CHE   29.3 (49)
History of breastfeeding 110 51.8 (57)
Vital status of parents at cART initiation 167  
 Mother dead   6.6 (11)
 Father dead   3.6 (6)
 Vital status of the father unknown (or data missing)   6.6 (11)
Infants living with: 167  
 Both parents   50.3 (84)
 Mother only   37.7 (63)
 Other caregivers   12.0 (20)
Presence of functional fridge at home 115 43.5 (50)
Difficulty with remembering to give cART medication   
 M3 138 33.3 (46)
 M12 123 24.4 (30)
 M24 81 29.6 (24)
Clinical status at cART initiation 167  
 WAZ (median, IQR)   −0.2 (−0.4; −0.1)
 History of hospitalization   41.3 (69)
CD4 count (%) at cART initiation (median, IQR) 161 23 (15 ; 32)
Viral load at cART initiation (log10 cp/mL) (median, IQR) 166 6.5 (6.0 ; 6.9)
Age at cART initiation 167  
  < 6 months   80.8 (135)
 6–12 months   16.8 (28)
  > 12 months   2.4 (4)
 In months (median, IQR)   4.0 (3.0–9.0)
Type of first cART 167  
 Protease inhibitor-based regimen   63.9 (110)
 Nevirapine-based regimen   34.1 (57)
  1. N total number, n number of children in the group, CME/FCB Centre Mère et Enfant/Fondation Chantal Biya, Yaounde, HLD Hôpital Laquintinie, Douala, CHE Centre Hospitalier d’Essos, Yaounde, Mx delay from cART initiation to the current visit, e.g. «M3» means «3 months after cART initiation», cART combination antiretroviral therapy, % percentage, n number of patients in the cell, WAZ Weight for Age Z score based on WHO reference tables, IQR interquartile range, CD4 lymphocytes that have CD4 marker